TCL Archive Two Breast Cancer Program Announcements Listed On Screening, Genetic Susceptibility February 1, 1980
TCL Archive Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer November 20, 1992
TCL Archive Clearinghouse Exec. Secty, Says It Has Failed in Its Objectives, Recommends It Be Dropped January 13, 1978
TCL Archive In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting November 14, 1975
TCL Archive NCI’s Otis Brawley Named Professor At Emory, Associate Director, Cancer Control, At Winship. April 20, 2001
